U.K.-based Dechra Pharmaceuticals has spent much of the past year rolling out a global expansion plan that's largely focused on increasing its presence in…

Zoetis spent much of 2015 slimming down and developing new products most likely to capitalize on demand trends in animal health. Those moves seem to be paying…

Pet hospital chain VCA was in a precarious position in the third quarter, missing revenue forecasts despite a beat on earnings. The company found its footing…

Phibro Animal Health missed expectations in its second fiscal quarter, reporting after the market closed on Feb. 9 that it earned $0.39 a share on $192 million…

Eli Lilly's $5.4 billion acquisition of Novartis Animal Health left it with excess manufacturing capacity that it has spent much of the past year trying…

Shares of Aratana Therapeutics jumped 25% to $3.99 a share in after-market trading on January 25, after the company announced it had filed for FDA approval of…

Most of IDEXX Laboratories' revenues come from the rapidly growing animal health industry, so CEO Jonathan Ayers focused his entire presentation at the J.…

Zoetis has been working hard this past year to turn things around, implementing a major plan to cut costs in order to boost business. But now the company is…